This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boudoulas, H. Articles by Weissler, A. M. Search for Related Content PubMed PubMed Citation Articles by Boudoulas, H. Articles by Weissler, A. M.

Circulation, Vol 60, 164-169, Copyright © 1979 by American Heart Association

ARTICLES

Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion

H Boudoulas, SE Rittgers, RP Lewis, CV Leier and AM Weissler

Diastolic time (DT) is calculated as the cycle length (RR) minus electromechanical systole (QS2). The ratio of DT (RR-QS2) to RR interval times 100, or the percent diastole (%D), varies nonlinearly with heart rate (HR), increasing rapidly with decreasing HR. The effect of commonly used cardioactive agents on %D was studied in five groups of normal subjects. In group 1 (n = 12), propranolol (160 mg daily) increased %D from 55.9 +/- 1.7 to 64.7 +/- 1.3 (p less than 0.001) by slowing HR. In group 2 (n = 12), dobutamine (2.5 micrograms/kg/min) increased %D from 56.4 +/- 1.4 to 61.8 +/- 1.3 (p less than 0.005) by shortening the QS2. In group 3 (n = 10), Cedilanid-D (1.6 mg i.v.) increased %D from 55.5 +/- 1 to 63.2 +/- 0.7 (p less than 0.001), both by slowing the HR and shortening the QS2. In group 4 (n = 12), isoproterenol (2 micrograms/min) increased HR and shortened the QS2 significantly. The net result was a significant reduction of %D from 56.1 +/- 1.4 to 53.5 +/- 1.1, (p less than 0.05). In group 5 (n = 15), a 100-mg bolus of i.v. lidocaine did not have a significant effect on %D. This study indicates that cardiovascular drugs may have significant effects on the relative duration of diastole either by affecting HR or the duration of systole. This may have clinical implications for patients with coronary artery disease and patients with left ventricular hypertrophy, since in both cases coronary flow in mostly diastolic.

This article has been cited by other articles:

				H. Matsumoto, T. Kondo, S. Watanabe, R. Kikumoto, T. Shimada, Y. Hiraoka, and K. Ueda ECG-Edited Middiastolic Phase Reconstruction Improves Image Quality at 64-MDCT Coronary Angiography of Patients with Atrial Fibrillation Am. J. Roentgenol., December 1, 2008; 191(6): 1659 - 1666. [Abstract] [Full Text] [PDF]

				C. Kolyva, B.-J. Verhoeff, J. A. E. Spaan, J. J. Piek, and M. Siebes Increased diastolic time fraction as beneficial adjunct of {alpha}1-adrenergic receptor blockade after percutaneous coronary intervention Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2054 - H2060. [Abstract] [Full Text] [PDF]

				D. S. Fokkema, J. W. G. E. VanTeeffelen, S. Dekker, I. Vergroesen, J. B. Reitsma, and J. A. E. Spaan Diastolic time fraction as a determinant of subendocardial perfusion Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2450 - H2456. [Abstract] [Full Text] [PDF]

				T. Nakanishi, Y. Kayashima, R. Inoue, K. Sumii, and Y. Gomyo Pitfalls in 16-Detector Row CT of the Coronary Arteries RadioGraphics, March 1, 2005; 25(2): 425 - 438. [Abstract] [Full Text] [PDF]

				C. S. Chung, M. Karamanoglu, and S. J. Kovacs Duration of diastole and its phases as a function of heart rate during supine bicycle exercise Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2003 - H2008. [Abstract] [Full Text] [PDF]

				C. Hong, C. R. Becker, A. Huber, U. J. Schoepf, B. Ohnesorge, A. Knez, R. Bruning, and M. F. Reiser ECG-gated Reconstructed Multi-Detector Row CT Coronary Angiography: Effect of Varying Trigger Delay on Image Quality Radiology, September 1, 2001; 220(3): 712 - 717. [Abstract] [Full Text] [PDF]

				D. Chemla, E. Aptecar, J.-L. Hebert, C. Coirault, D. Loisance, Y. Lecarpentier, and A. Nitenberg Short-term variability of pulse pressure and systolic and diastolic time in heart transplant recipients Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H122 - H129. [Abstract] [Full Text] [PDF]

				B. Andersson, S.-O. Stromblad, M. Lomsky, and F. Waagstein Heart rate dependency of cardiac performance in heart failure patients treated with metoprolol Eur. Heart J., April 2, 1999; 20(8): 575 - 583. [Abstract] [PDF]

				T Laperche, D Logeart, A Cohen-Solal, and R Gourgon Potential interests of heart rate lowering drugs Heart, April 1, 1999; 81(4): 336 - 341. [Full Text]

				P. Mulder, V. Richard, F. Bouchart, G. Derumeaux, K. Munter, and C. Thuillez Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure Cardiovasc Res, September 1, 1998; 39(3): 600 - 608. [Abstract] [Full Text] [PDF]

				D. Gee, R. Wilson, and D. Angello Acute Effect of Lidocaine on Coronary Blood Flow and Myocardial Function Angiology, January 1, 1990; 41(1): 30 - 35. [Abstract] [PDF]

				C. V. LEIER and D. V. UNVERFERTH Drugs Five Years Later: Dobutamine Ann Intern Med, October 1, 1983; 99(4): 490 - 496. [Abstract] [PDF]

				T. Winsor, D. W. Winsor, B. G. Krohn, and J. R. Bernett Effect of Coronary Vasodilating Drug on Myocardial Work Angiology, June 1, 1982; 33(6): 393 - 400. [Abstract] [PDF]